Xeriant, Inc. (OTCQB: XERI), (“Xeriant” or “the Company”), dedicated to the discovery, development and commercialization of transformative technologies, today announced that it has completed its ...

When internet services platform Cloudflare suffered an outage in November, it took a big chunk of the online world down with it. Major platforms like ChatGPT, X, and Canva became unreachable. So did ...

Aegis.Net Inc. recently was selected by the National Institute of Standards and Technology to establish a health IT test infrastructure that verifies conformance and interoperability with industry ...

As organizations grow and embrace digital transformation, their software systems are becoming more complex than ever. With innovation moving at breakneck speed, enterprises are now rolling out updates ...

KPMG pilots removal of humans from routine testing of things like payroll and expenses, with greater reliance on AI agents.

Out-of-step protection is a critical component of modern power system protection schemes—its importance has grown significantly with the increasing penetration of inverter-based resources (IBRs) and ...

Viavi Solutions, Inc. VIAV recently announced the launch of the CX200 infrastructure field tester. The solution is designed to streamline testing, maintenance and troubleshooting processes for mission ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. MADISON, WI - JUNE 06: U.S. Geological Survey (USGS) Wildlife ...

ANAHEIM, Calif.--(BUSINESS WIRE)--National Technical Systems, Inc. (“NTS”), the leading independent provider of qualification testing, inspection, and certification solutions in North America, is ...

Today, Premier Doug Ford was in North Bay to mark a critical step in the Northlander passenger rail service’s return to service later this year, 14 years after it was cancelled ...

Genetic testing, including germline and somatic, is vital for prostate cancer prognosis and personalized treatment strategies. PARP inhibitors, targeting BRCA mutations, are a promising therapy for ...